Kovack Advisors’s Johnson & Johnson JNJ Stock Holding History

Kovack Advisors’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-3	Closed	-$4.87K	–	640
2022 Q4	$4.87K	Buy	3 +1	+50%	+$173	﹤0.01%	542
2022 Q3	$3K	Buy	2 +1	+100%	+$169	﹤0.01%	552
2022 Q2	$2K	Buy	+1	New	+$178	﹤0.01%	605
2021 Q3	–	Sell	-1	Closed	-$1K	–	728
2021 Q2	$1K	Hold	1	–	–	﹤0.01%	690
2021 Q1	$1K	Hold	1	–	–	﹤0.01%	630
2020 Q4	$1K	Hold	1	–	–	﹤0.01%	609
2020 Q3	$1K	Hold	1	–	–	﹤0.01%	515
2020 Q2	$1K	Buy	+1	New	+$146	﹤0.01%	493
2019 Q2	–	Sell	-1	Closed	-$1K	–	495
2019 Q1	$1K	Buy	+1	New	+$134	﹤0.01%	452

Other funds holding JNJ

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

AACR

ACR Alpine Capital Research St. Louis, Missouri $7.04B AUM 28% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

Kovack Advisors's JNJ Position: Q2 2026 in Review

Kovack Advisors reduced its Johnson & Johnson (JNJ) stake by 8.7% in Q2 2026, selling an estimated $446K and leaving 20,128 shares worth $5.11M. The position accounts for 0.25% of the portfolio, ranked #82.

Kovack Advisors first reported a position in JNJ in Q3 2013 and has held it in 51 quarters since. The position peaked at $7.48M in Q4 2025. 2,122 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

Kovack Advisors held 20,128 shares of Johnson & Johnson worth $5.11M as of Q2 2026.
Kovack Advisors sold 1,912 Johnson & Johnson shares in Q2 2026, an estimated $446K.
Johnson & Johnson made up 0.25% of Kovack Advisors's portfolio in Q2 2026, its #82 holding.
Kovack Advisors first reported a position in Johnson & Johnson in Q3 2013 and has held it in 51 quarters since.
Kovack Advisors's Johnson & Johnson position peaked at $7.48M in Q4 2025.
2,122 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Kovack Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.